Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.850
+0.4804.22%
Volume:8.01M
Turnover:94.39M
Market Cap:30.43B
PE:18.79
High:11.890
Open:11.250
Low:11.250
Close:11.370
52wk High:14.081
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:3.05
T/O Rate:0.31%
Dividend:0.21
Dividend Rate:1.77%
EPS(LYR):0.631
ROE:18.77%
ROA:7.78%
PB:2.76
PE(LYR):18.79
PS:2.99

Loading ...

Simcere Pharma Wins Promotion Rights for PrimeGenX's Atopic Dermatitis Drug

MT Newswires Live
·
Jun 02

BRIEF-Simcere Pharmaceutical Enters Exclusive Promotion Service Agreement With Primegenx Therapeutics

Reuters
·
Jun 01

Simcere Pharma, PrimeGenX Ink Exclusive Promotion Deal for Pumecitinib Gel in Greater China

Bulletin Express
·
Jun 01

SIMCERE PHARMA Secures Exclusive Rights to Promote Pemecitinib Gel

Stock News
·
Jun 01

Simcere signs exclusive promotion pact with PrimeGenX for pumecitinib gel in Greater China

Reuters
·
Jun 01

Simcere Pharmaceutical - Obtains Exclusive Promotion Rights for Pumecitinib Gel in China, Hong Kong, Macau

THOMSON REUTERS
·
Jun 01

Simcere Pharmaceutical - - Entering Into an Exclusive Promotion Service Agreement With Primegenx Therapeutics

THOMSON REUTERS
·
Jun 01

SIMCERE PHARMA Executes HK$8.7 Million Share Buyback on May 22

Deep News
·
May 25

SIMCERE PHARMA Spends HK$8.7 Million on Share Buyback

Stock News
·
May 22

Simcere Pharma adds 0.83 million-share buyback; 27.50 million shares now pending cancellation, 1.11% of capital

Bulletin Express
·
May 22

Simcere files HKEX next-day return, discloses share repurchase at HKD 10.49 each

Reuters
·
May 22

Simcere Pharma Releases AGM Circular and Switches to Fully Electronic Corporate Communications

Bulletin Express
·
May 21

Simcere Pharma Sets 12 June 2026 AGM; Board Seeks Approval for RMB0.18 Final Dividend, 20% Issuance Mandate and 10% Buyback Limit

Bulletin Express
·
May 21

Simcere Releases AGM Circular and Adopts Full e-Communication Framework

Bulletin Express
·
May 21

Simcere Pharma Plans 20% Share Issue Mandate, 10% Buyback, RMB0.18 Final Dividend and Board Changes Ahead of 12 June 2026 AGM

Bulletin Express
·
May 21

Simcere Pharma Issues AGM Notice, Proposes RMB0.18 Final Dividend and Director Re-election

Bulletin Express
·
May 21

Simcere Pharma reports 26.67 million-share buyback awaiting cancellation; issued share count unchanged

Bulletin Express
·
May 21

SIMCERE PHARMA Executes HK$21.74 Million Share Buyback

Stock News
·
May 20

Simcere Pharma further buys back 2.58 million shares; YTD repurchases reach 20.57 million

Bulletin Express
·
May 19

Simcere files HKEX next-day return, discloses share buyback at HKD 11.48 each

Reuters
·
May 19